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Abstract:

Discussion:

We report the case of a 38 year old male physician
who was vaccinated with the Pfizer. He
experienced arm pain and swelling on the
vaccinated arm as well as systemic symptoms ,
including fever, chills, headache and weakness.
The systemic symptoms improved after the use of
oral prednisone. A review of the literature on
COVID vaccine article is presented.

Epidemiology and terminology of COVID arm (COVID
vaccine arm) Approximately 2% of patients who received an
mRNA vaccine COVID vaccine report at least a mild skin
reaction at the vaccination site. [3,5] The reaction has been
called "COVID arm". Some authors believe the reaction
should be more properly called “COVID vaccine arm". [4]
COVID vaccine arm is characterized by erythema and edema
at the vaccination site and can present up to 10 days post
vaccination and can emerge at sites adjacent or distant to
the vaccination site.
Mechanism The mechanism of COVID vaccine arm has not
been clearly established. Both the Moderna and Pfizer
vaccines include mRNA and lipids. These vaccines contain
polyethylene glycol. According to Lingren et al, polyethelene
glycol compounds "have previously been shown to cause
delayed hypersensitivity reactions", however they note that
it unclear if these are the cause of COVID vaccine arm. [5,6,7]
Presentation In a systematic review of the literature by
Fasano et al, it was noted that 24% of patients with COVID
vaccine arm experienced not only with arm swelling but with
systemic symptoms, such as myalgias, chills and headache.
Lymphadenopathy has also been described. This is
consistent with the patient presented in this case. [3] Lindren
et al point out that Phase 3 Moderna data suggest that
COVID arm occurs less frequently on the second dose than
the first dose. [4,5]
Differential diagnosis COVID vaccine arm present as a
cellulitis. A recent tick bite can be a clue for erythema
migrans.
Treatment Patients with mild symptoms may not require
and treatment. The reaction is generally self-limited. [2]
Management can include diphenhydramine and topical
steroids. Oral steroids have been used. In the case presented,
oral prednisone appears to have had a salutary effect on the
patient's systemic symptoms. An awareness of COVID
vaccine arm may reduce the use of antibiotics for suspected
post vaccination cellulitis. [1]

Case Presentation:
A 38 year old male physician was vaccinated with
the Pfizer COVID vaccine. He noted some shoulder
soreness on the side of the vaccination ( left deltoid
) on the day of the vaccination. Later that evening
he noted chills and rigors in association with
swelling and tenderness of his left upper arm in the
area of the vaccination site. The rigors and
headache persisted throughout the night. In the
morning (day 1 after vaccination) he noted a diffuse
sharp headache accompanied by an overall sense of
weakness in association with subjective fever. In
addition, he developed axillary edema. He noted
some improvement with acetaminophen and
ibuprofen. That night he again experienced rigors.
On post-vaccine day two he developed a diffuse
headache and fatigue. On the morning of day two
post vaccination, he took 60 mg of prednisone and
25 mg of diphenhydramine with noticeable
improvement in symptoms within two hours of
taking the medicine and with near resolution within
12 hours. He slept well on the night of day two with
no rigors. On day three the patient awoke without
headache of weakness and continued prednisone
(60 mg on day 3) as well as diphenhydramine 25 mg
three times per day. He discontinued medications
on day 4. The arm swelling subsided and resolved
over the next several days. The patient’s symptoms
had entirely resolved by day 5 post vaccination.

Conclusions:
COVID vaccine arm with systemic symptoms may improve
with oral diphenhydramine and oral corticosteroids. An
awareness of COVID vaccine arm may reduce the use of
antibiotics for suspected post vaccination cellulitis.
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